Compare WCC & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WCC | ICLR |
|---|---|---|
| Founded | 1922 | 1990 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.4B | 13.1B |
| IPO Year | 1997 | 2001 |
| Metric | WCC | ICLR |
|---|---|---|
| Price | $293.54 | $204.52 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 18 |
| Target Price | ★ $418.09 | $231.29 |
| AVG Volume (30 Days) | 758.9K | ★ 1.2M |
| Earning Date | 10-29-2026 | 10-27-2026 |
| Dividend Yield | ★ 0.70% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 12.77 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $14.33 | N/A |
| Revenue Next Year | $8.04 | $4.60 |
| P/E Ratio | $24.80 | ★ $12.91 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $240.55 | $66.57 |
| 52 Week High | $388.64 | $219.04 |
| Indicator | WCC | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 35.53 | 63.94 |
| Support Level | $255.43 | $157.92 |
| Resistance Level | $373.24 | $219.04 |
| Average True Range (ATR) | 16.66 | 9.19 |
| MACD | -5.34 | 0.99 |
| Stochastic Oscillator | 6.79 | 67.62 |
Wesco can be traced back to the late 1800s but was officially founded in 1922, acting as the distribution arm of Westinghouse Electric. Throughout the 1900s, Wesco entered and subsequently exited the consumer electronics, transit, bottling, and nuclear plant distribution markets. It was sold to a private equity firm in 1994 and then went public in 1999, and numerous acquisitions have since been made to fill the gaps in Wesco's geographical and product coverage. Today, the firm primarily distributes electrical, networking, security, and utility equipment used in the construction and repair of structures such as offices, data centers, power transmission lines, and manufacturing plants. Wesco has operations around the globe but generates the majority of its revenue in the United States.
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.